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Recombinant immune interferon, (interferon-y, IFN-7) inhibits types I and III collagen synthesis by rheu- 
matoid synovial fibroblast-like cells in culture. This decrease is associated with a decrease in the levels of 
types I and III procollagen mRNAs in these cells as measured by dot blot hybridization. In the control 
synovial cells the level of a2(I) mRNA is disproportionately high c~,mpared with that of ~I(I) or al(III) 
mRNA, and IFN-y suppresses the level of ~1(I) and al(III) mRNA to a greater extent han that of a2(I) 
mRNA. The lymphokine, IFN-7, may thus have a role in the regulation of collagen synthesis in inflammato- 
ry joint disease and other conditions. 
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1. INTRODUCTION 
In inflammatory joint disease, exemplified by 
rheumatoid arthritis, a heterogeneous population 
of cells infiltrates the synovial membrane [1]. Most 
of the cells in the infiltrate are mononuclear cells, 
particularly monocyte/macrophages and T lym- 
phocytes. Other abundant cells, however, are 
fibroblast-like, and are possibly related to normal 
synovial ining 'B' cells. In primary culture, many 
of the latter cells have a distinctive stellate ap- 
pearance and synthesize relatively large amounts 
of latent collagenase and prostaglandin E2 (PGE2) 
[2]. Cultures of these cells also synthesize and 
release procollagens, particularly types I and III, 
as well as fibronectin [3,4]. During the course of 
studies designed to further characterize these 
Abbreviations: IFN-y, interferon-y; PGE2, prostaglan- 
din Ez; cDNA, complementary DNA; SDS-PAGE, 
SDS-polyacrylamide g lelectrophoresis 
adherent cells from rheumatoid synovium, we 
observed that some of them expressed HLA-DR 
(Ia-like) antigens, as assessed by indirect im- 
munoperoxidase techniques with a primary 
monoclonal antibody directed against HLA-DR 
[5]. Ia antigens were not detected, however, in 
cultures of these ceils after the first passage, at 
which time mononuclear cells had largely disap- 
peared. Nevertheless, the adherent fibroblast-like 
cells continued to synthesize collagens, as shown, 
for example, by positive staining with a 
monoclonal antibody specific for human type III 
collagen. Some monocytes, B lymphocytes and ac- 
tivated T lymphocytes express HLA class II 
molecules. Immune interferon IFN-7 [6,7] not on- 
ly augments the expression of class II antigens on 
these immune cells but also induces the expression 
of HLA-DR antigens on a variety of nonimmune 
cells including fibroblasts and endothelial ceils 
[8-10]. When we incubated the synovial 
fibroblast-like cells with recombinant IFN-7, we 
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also observed the expression of Ia antigens and, in 
addition, a striking decrease in the extent and in- 
tensity of staining with the type III collagen an- 
tibody. In vivo, and m primary culture, the IFN-y 
would presumably be derrved from T lymphocytes 
in the ln~ammatory infiltrate. 
We show here that IFN-y decreases the synthesis 
of types I and III collagens by these synovlal 
fibroblast-like cells, as measured by incorporation 
of [3H]proline into medium procollagens and, con- 
comitantly, decreases the cellular content of types 
I and III procollagen mRNAs as assayed by 
hybridization with cDNA probes of the pro- 
collagens al(I), @2(I), and tvl(II1). 
2. MATERIALS AND METHODS 
Synovium was obtained at the time of joint 
surgery from patients with rheumatoid arthritis. 
The lining layer was dissected from the underlying 
capsule and the cells dispersed sequentially with 
clostrrdial collagenase and trypsin as described 
[1,1 11. Cultures of the adherent cells were main- 
tained m Dulbecco’s modification of Eagle’s 
medium (DME medium, GIBCO) containing 10% 
fetal calf serum in lo-cm plastic culture dishes 
(Falcon) in an atmosphere of 5% CO2 in air at 
3’7°C. After 4-8 weeks in culture and after passage 
by trypsinization, ~ytoplasmic RNA was extracted 
from confluent cells, and in separate cultures col- 
lagen synthesis was measured. For comparison, 
cultured normaI human dermal fibroblasts were 
also used (no.390, provided by Dr R.W. Erbe, 
Genetics Unit, Massachusetts General Hospital). 
2.2. Colfagen syntheses 
Cultures were Incubated with or without IFN-y 
(prepared by recombinant DNA methodology and 
kindly provrded by Genentech Inc., South San 
Francisco, CA) in 3.5cm diameter six-well trays 
with DME medium, 10% fetal calf serum, for 2 
days at 5 x 105 cells/ml. The medium was re- 
moved, cells washed 3 times with DME medium, 
and 1.0 ml fresh DME medium without fetal calf 
serum containing 50 pg/ml ~-aminopropionitrile, 
50pg/ml ascorbic acid, 2 mM glutamine and 
20 &i L-[5-3H)proline (30 Cilmmol, Amersham 
Searle, Arlington Hts, IL) was added, and incuba- 
tion continued for an additional 24 h. The medium 
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was then removed and ahquot portions analyzed 
by SDS-PAGE (5Yo acrylamide) [12] with and 
without reduction with 0.5% ~-mercaptoethanol. 
14C-labeled rat tail tendon collagen ]13] was used 
as an M, marker. The labeled collagen m the cell 
culture medium was further characterized folfow- 
ing pepsinization at 4”C, and the collagens ana- 
lyzed by SDS-PAGE with delayed reduction to 
distinguish al(I) from cul(II1) chains [14]. 
Fluorograms of the geis were prepared as descrrbed 
llS1. 
2.3. Extraction of RNA 
Cytoplasmic RNA was extracted from confluent 
synovial cells in the first passage or normal human 
dermal fibroblasts after several passages (- 1 x lo6 
total cells) after lysing the cells with Nonidet P-40, 
pelleting the nuclei and treating the cytoplasmi~ 
supernate with formaldehyde according to White 
and Bancroft [16]. Total RNA which served as a 
human dermal fibroblast standard, was extracted 
and purified from -10’ cells usmg the guanldine 
hydrochloride techmque [ 17,18]. RNA solutions 
were stored at - ‘70°C until analysis. RNA concen- 
tration was calculated from the A26enm using the 
absorbancy index of 2 1.4 cm2 -mg- ’ . 
2.4. Preparation of DNA probes 
The cDNA probes used were as follows: human 
al(I) procollagen, Hf 677, is of -1500 bases; 
human cu2(1) procollagen, Hf 1131, is of - 1500 
bases; and human acl(II1) procollagen, pHC III-I, 
is of -1885 bases. Each of these cDNA probes in- 
cludes a portion of the helical region and the C- 
terminal propeptide. The cDNA probes for al(I) 
[ 19,201 and cy2(1) [20-225 procollagens were kindly 
provided by Drs F. Ramirez and D.3. Prockop, 
University of Medicine and Dentistry of the New 
Jersey-Rutgers Medical School. The cDNA probe 
for al(II1) procollagen was kindly provided by Drs 
R. Jo Crystal and M. Brantly, Natronal Instrtutes of 
Health. In order to compare dot blots, probes had 
to be similar in size and long enough to be outside 
of the highly conserved sequences to avoid cross 
hybridization. Both cloned cDNAs for type I col- 
lagen were selected because they were approx- 
imately the same size, were highly homologous in 
terms of their base sequences, and encoded 
analogous regions of the pro al(I) and pro tu2(1) 
chains 1201. They dtd not cross hybridize. The 
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plasmtds, pBR322, containing the cDNA inserts 
were grown in strains of Escherrchra co11 and 
isolated from cesium chloride gradients [23]. Each 
of the probes, 1 ,ug, was nick-translated using 
[cu-32P]dGTP and [a-32P]dCTP (-700 Ct/mmol, 
New England Nuclear, Boston, MA) without exct- 
ston from the plasmid. A nick translation kit was 
used (BRL, Inc, Gaithersberg, MD). After label- 
mg, the probes were put through two l-ml 
Sephadex G-100 columns (Pharmacia P-L 
Biochemicals, Piscataway, NJ). The specific ac- 
tivities of the labeled probes were as follows: al(I) 
procollagen, HF677 = 6.10 x 10’ cpm/pg DNA; 
a2(1) procollagen, HF1131 = 6.36 x 10’ cpm/pg 
DNA and al(II1) procollagen, pHC III-I = 
5.20 x 10’ cpm/pg DNA. 
2.5. Assay of hybrldrzable mRNA 
Dot blots were prepared using a filtration ap- 
paratus (‘Mimfold Schleicher and Schuell, Keene, 
NH). Appropriate dilutions of the RNA samples 
were made in 15 x SSC (1 x SSC = 0.15 M sodium 
chloride, 0.015 M sodmm citrate, pH 7.5) and 
100~1 of each were filtered gently onto 
mtrocellulose paper (B A 85, 0.45 pm pore 
diameter, Schleicher and Schuell) that had been 
presoaked in 20 x SSC and dried; 100~1 of 15 x 
SSC were filtered both before and after addition of 
the sample. The papers were air-dried and baked 
for 3 h in vacua at 80°C. Prehybridization was 
carried out for 4-6 h at 42°C in a solution contain- 
mg 50% formamide, 5 x SSC, 0.3% SDS, 0.1% 
each bovine serum albumin, Ficoll, and 
polyvmylpyrrolidone and 100 fig/ml sonicated 
salmon testis DNA, heated at 95°C for 10 min just 
prior to addition. These conditions were modified 
from those of Thomas [24]. Total plasmid 32P- 
labeled probe, 1 ,ug, along with 200 fig yeast tRNA 
was taken up m 15 ml of the same solution after 
being heated at 90°C for 5 mm. Hybridization was 
at 42°C for 24 h. The papers were washed in 0.5 x 
SSC at 50°C with 4 changes during a 2-h period, 
then air-dried. Radioautography was performed at 
-70°C using Kodak X-AR film with DuPont 
Chronex Lightning-Plus intensifying screen [25]. 
Quantitation of hybridizable mRNAs was per- 
formed by counting the excised dot blots using 
‘Omnifluor’ (New England Nuclear, Boston, MA) 
or by densitometric analysis of the radioauto- 
graphs. Scanning densitometry was performed on 
underexposed autoradiograms of the dot blots 
where there was a linear response to the concentra- 
tions applied. In some cases two exposures of the 
same gel were scanned to assure the linear 
response. 
3. RESULTS 
3.1. Synthesis of procollagens 
The adherent synovial cells synthesized and 
released partially processed procollagens as well as 
a molecule with electrophoretic haracteristics con- 
sistent with fibronectin (fig.l), as m [3,4]. Fully 
processed collagen al(I) and cu2(1) chains were not 
detected in the medium proteins. Incubation of 
these cells with 100 units of IFN-7 markedly sup- 
pressed the synthesis of procollagens (types I and 
III) and to some extent, fibronectin, as well. This 
suppression of synthesis of types I and III col- 
lagens was also observed after pepsinization of the 
medium proteins (fig.2). The ratio of a1(1)/&2(1) 
chains in medium proteins from control cells was 
-2.2 as determined by densitometric analysis of 
the fluorograms. The percent inhibition by IFN-7 
of the collagen synthesized and released into the 
culture medium was 80% for al(I), 87% for cu2(1) 
and 79% for al(II1). IFN-y similarly inhibited col- 
lagen synthesis by the normal dermal fibroblasts 
(not shown) in agreement wtth a recent finding of 
Jiminez et al. [26]. 
3.2. Levels of procollagen mRNAs 
As shown in fig.3, mRNA, which hybridized 
with the probes for human al(I) and a2(1) pro- 
collagens, was readily detected m cytoplasmic 
RNA of cultured rheumatoid synovial cells 
(fig.3A,B) as well as in the cytoplasmic RNA and 
total RNA extracted by the guamdme- 
hydrochloride method from the strain of normal 
dermal fibroblasts (fig.3C,D). The ratio of 
c~l(I)/cu2(1) procollagen hybridizable mRNAs in 
the dermal frbroblast preparations averaged 2.13 
for the cytoplasmic RNA and 2.01 for the total 
RNA (table 1, experiment 1; fig.3) consistent with 
values previously reported using these probes [20]. 
In the rheumatoid synovial cell RNA (fig.3A), 
however, the ratio of ~1(1)/(~2(1) procollagen 
hybridizable mRNAs averaged 0.84. The levels of 
type I procollagen mRNAs in synovial cells 
45 
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Fig 1. Effect of IFN-y on proteins secreted by adherent 
rheumatoid synovial cells Fluorogram of SDS-PAGE 
of 3H-labeled medium from confluent cells incubated 
alone (lanes A,C) or with 100 units/ml IFN-7 (lanes 
B,D) descrtbed m section 2. Medmm (50 al) was mixed 
wtth 50 ~12 x sample buffer without (lanes A,B) or with 
(lanes C,D) 0.5% &mercaptoethanol. Tubes were 
stoppered and heated to 60°C for 20 mm, then 80 ,ul 
ahquots were applied to each lane Film was exposed to 
gel for 3 days The position of the labeled protein was 
determined usmg 14C-rat ad tendon collagen as marker 
Fibronectm migrates lust below collagen y component 
under non-reducing condtttons (A,B) and m the regton 
of @1,2 under reducing condntons (C,D) The major 
bands migrating between ac-chains and/31,2 components 
are processed type I and III components. 
previously incubated with 100 units IFN-7 were 
markedly depressed (fig.3B). This depresston was 
more striking using the al(I) procollagen cDNA 
probe (73% inhibition) compared with the o2(1) 
procollagen probe (39% inhibition). 
Srmtlar results were obtained with a later culture 
of rheumatoid synovial cells (fig.4; table 1, experi- 
ment 2). In control synovtal cells (frg.4A), the ratio 
of c~l(I)/~~2(1) procollagen mRNAs averaged 1.14. 
The levels of both these mRNAs were reduced m 
c 
Fig.2 Effect of IFN-7 on types I and III collagen 
syntheses by adherent rheumatoid synovtal cells. 
Fluorogram of SDS-PAGE analysts of pepsmrzed 3H- 
medium proteins, run using delayed reduction to 
separate al(II1) from al(I) chains. Ahquots were from 
the same media used in ftg. 1. Medium was from control 
cells (A) or cells incubated with IFN-7 (100 umts/ml) 
(B) Medium (100~1) from each was mixed wtth 100~1 
pepsm solutton (2 mg/ml pepsin [Worthington] m 1 M 
acetic acid) at O’C. After 18 h at 5°C samples were 
lyophthzed to remove the acetic acid; 50~1 Hz0 and 
then 50~1 2 x sample buffer were added, the tubes 
stoppered and heated to 60°C for 20 mm; 80~1 were 
applied to each lane with 10% P-mercaptoethanol in 
50 ,~l sample buffer added to wells after samples had run 
-2 cm mto the separating gel. The film was exposed to 
the gel for 8 days. 
extracts of cells incubated with 100 units IFN-7 
(frg.4B). The pattern of reduction was similar to 
that observed in fig.3 in that levels of al(I) pro- 
collagen mRNA were suppressed to a greater ex- 
tent than those of a2(1) procollagen mRNA (77% 
vs 44% mhibitton, respectively). It can also be seen 
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m fig.4 that mRNA for ~ul(II1) procollagen IS pre- 
sent tn these synovial cells but at a lower abun- 
dance than that for the al(I) or a2(1) procollagens. 
Ratios of (~l(I)/al(II1) procollagen mRNAs were 
approx.17 in the dermal fibroblasts (fig.4C) and 
approx.4 in the synovial cells not incubated with 
IFN-y (fig.4A). IFN-7 also suppressed the levels of 
~~l(I11) procollagen mRNA in the synovial cells 
Fig 3. Dot blot hybridization of 32P-labeled al(I) and 
cu2(I) procollagen probes to cytoplasmtc RNA from 
human rheumatoid synovial cells and cytoplasmic and 
total RNA from dermal fibroblasts. Cells were passaged 
4 days prror to use. Cytoplasmtc RNA was extracted 
from one IO-cm diameter culture dish for each culture 
condrtron, which contamed -1 x lo6 cells. Drluttons 
were made in 15 x SSC and the cytoplasmrc RNA from 
the equtvalent of -5 x 104, 1 x lo4 and 2 x 10’ cells 
applied to the mtrocellulose paper in vertical rows 1, 2 
and 3, respectively. (A) Rheumatoid synovial cells; (B) 
rheumatoid synovral cells incubated wrth 100 units/ml 
IFN-y for 48 h prior to extraction of RNA; (C) human 
dermal frbroblasts; (D) total RNA from human dermal 
ftbroblasts filtered at -2.0, 0.40 and 0 08 pg RNA. The 
same amounts were used for both probes and filtered on 
the same sheet. 
(fig.4B) (68% inhibition) consistent with the 
observed suppression of synthesis of type III col- 
lagen present m medium proteins (fig.2). 
The IFN-y also suppressed levels of type I pro- 
collagen mRNAs in the dermal fibroblasts. This ef- 
fect (20% inhibition) was observed at 10 units/ml 
IFN-7 (not shown). 
Table 1 
Levels of mRNA for types I and III procollagens m rheumatotd synovral frbroblast-like cells and normal dermal 
frbroblasts 
Experr- Cell-type mRNA 
ment source 
Ratio % Decrease by IFN-y 
pro cvl(I)/pro cuZ(I) 
pro al(I) pro cu2(1) pro al(III) 
1 Normal dermal frbroblast 2.13a 
2.01b 
Rheumatoid synovral cell 0.84= 
Rheumatoid synovtal cell + IFN-7 0.38a 73 39 
2 Normal dermal frbroblast 2.30b 
Rheumatoid synovral cell 1.14= 
Rheumatoid synovral cell + IFNy 0.50* 77 44 68 
Levels of mRNAs were quantitated densrtometrically from the autoradrograms hown m fig.3 (experrment 1) and fig.4 
(experiment 2). RNA preparations. a cytoplasmtc; b total 
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Ftg 4. Dot blot hybrtdtzatton of al(I), (~2(1) and cul(III) 
procollagen probes to cytoplasmic RNA from human 
rheumatoid synovial cells and total RNA from human 
dermal fibroblasts In another experiment (table 1, 
experiment 2) cells were grown to confluency (-1 X 
106/10 cm diameter dish) and passaged 28 days prior to 
extraction of cytoplasmtc RNA. Procedures same as in 
ftg.3. The cytoplasmrc RNA dtluttons were from the 
equivalent of -6 x 104, 3 x 104 and 1.5 x lo4 cells, 
respectively (vertical rows 1, 2 and 3), while total RNA 
from control dermal fibroblasts contained -1.0, 0.50 
and 0.25 pg RNA. (A) Rheumatoid synovtal cells; (B) 
rheumatoid synovtal cells with 100 units/ml IFN-7 for 
48 h prior to extraction of RNA, (C) total RNA from 
normal dermal frbroblasts. 
4. DISCUSSION 
It is evident from the results reported here that 
IFN-y inhibited collagen synthesis by the synovial 
cells, as shown by the decrease in incorporation of 
labeled proline into medium types I and III pro- 
collagens, which was accompanied by strikmgly 
decreased levels of hybridizable types I and III pro- 
collagen mRNAs. We do not yet know whether 
these decreases are accounted for by inhibition of 
transcription of the procollagen genes, altered pro- 
cessing of the transcript, altered transport from 
nucleus to cytoplasm or altered stability of the pro- 
cessed transcript [27]. If the decreased levels of 
these mRNAs do mvolve a decrease m transcrip- 
tion, then this effect has to be expressed at several 
different loci, since the human genes for the al(I) 
and &2(I) procollagens are located on different 
chromosomes, 17 and 7, respectively [28,29]. By 
analogy, in other conditions in which the levels of 
procollagen mRNAs are suppressed parallel to 
suppression of collagen protein synthesis, such as 
infection with Rous sarcoma virus, the effect is 
probably exerted at the level of transcription 
[30,31]. On the other hand, Focht and Adams [32] 
have recently shown that control of type I collagen 
gene expression may be exerted at both transcrtp- 
tional and posttranscrtptional levels. 
Of interest is our finding in the synovial cell 
preparation examined that the ratio of al(I)/cu2(1) 
procollagen mRNAs was considerably less than 2, 
the ratio predicted and observed in previous 
studies utilizing these cDNA probes [20] and con- 
firmed by us in the normal strain of fibroblasts. 
The reasons for the disproportronately high levels 
of the cu2(1) procollagen mRNA (or dispropor- 
tionately low levels of the al(I) procollagen 
mRNA) are not yet apparent. The relative increase 
in the levels of ~~2(1) procollagen mRNA was not, 
however, accompanied by an increase in secretion 
of pro a2(1) chains, since the ratio of medium 
cu1(1)/~~2(1) chains was greater than 2. We have not 
yet obtained sufficient numbers of adherent 
rheumatoid synovtal cells to characterize the 
hybridizable species and determine whether the 
hybridizable cu2(1) procollagen mRNA can be 
shown to consist of the normally processed 6.2, 5.7 
and 5.5 kb mRNAs [33]. 
The adherent synovial cells which persist in 
cultures prepared from the synovial lining of joints 
from patients with rheumatoid arthritis are 
fibroblast-like. In addition to collagenase, they 
synthesize types I and III procollagens and 
fibronectin but they can be induced to express Ia- 
like antigens with IFN-y. In early passages, 
however, they differ from fibroblasts cultured 
from dermis in that they produce higher amounts 
of collagenase and prostaglandins, the levels of 
which are increased many fold over that of dermal 
fibroblasts when incubated with the interleukin- 
l-like molecule, mononuclear cell factor [l]. The 
decreased ratio of ~~l(I)/cu2(1) procollagen 
mRNAs, compared to skin fibroblasts may m- 
dicate an additional difference among these cells. 
Our studies have demonstrated that IFN-y could 
be one of the lymphokines that inhibits collagen 
synthesis m vivo. Mononuclear cells produce both 
inhibitors and stimulators of collagen synthesis 
[1,3,4,34-401. We and others have demonstrated 
that PGE2 can inhibit collagen synthesis and secre- 
48 
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tion in certain cells [3,4,41,42], but it is unlikely 
that IFN-y 1s acting through control of 
arachidonate metabolism. IFN-y does not alter 
medium PGE2 synthesis induced by mononuclear 
cell factor [43] IFN-7 is thus a potentially rmpor- 
tant natural modulator of collagen syntheses in 
inflammation. 
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